Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
10-KT
Rhea-AI Filing Summary
Regenerex Pharma, Inc. (RGPX) is a Nevada-based wound-care company focused on proprietary technologies for chronic and acute wounds, centered on its QBx™ platform and primary product, Accelerex™. Regenerex targets diabetic ulcers, pressure ulcers, burns and surgical wounds and highlights clinical data it states show high closure rates in non‑healing chronic wounds.
For the nine months ended December 31, 2025, the company generated no revenue and reported a net loss of $2,543,211, similar to the $2,527,041 loss for the year ended March 31, 2025. Cash declined to $11,049 from $653,025, while current liabilities reached $5,169,186, resulting in a stockholders’ deficit of $5,001,304. The auditor and management disclose substantial doubt about Regenerex’s ability to continue as a going concern.
Operations have been funded by equity sales and related‑party and other notes payable; the company is seeking an additional $5,000,000 by September 2026. A March 2025 bank account hack led to a theft of funds, with partial recovery and a bank settlement recorded. Regenerex changed its fiscal year end to December 31 and discloses multiple related‑party arrangements, including an asset purchase with up to $10,000,000 contingent consideration and significant notes payable to related parties. The company reports new litigation it has initiated against its former CFO and a related entity, with outcomes not yet determined.
Positive
- None.
Negative
- Substantial doubt about going concern: continuing losses, negative operating cash flow and current liabilities exceeding current assets by $5,416,292 raise significant uncertainty about Regenerex’s ability to continue operating without new capital.
- No revenue and persistent losses: the company reported $0 revenue and a $2,543,211 net loss for the nine months ended December 31, 2025, following a $2,527,041 loss for the prior fiscal year.
- Very limited liquidity: cash and equivalents fell to $11,049 at December 31, 2025, from $653,025 at March 31, 2025, while total liabilities were $5,513,714.
- Material bank-theft incident: in March 2025 a hacking incident removed $399,680 from a company bank account; only $86,000 was recovered or settled, with the remainder representing a material loss.
